Literature DB >> 575330

Quantitative studies on the occurrence of praziquantel in milk and plasma of lactating women.

J Pütter, F Held.   

Abstract

10 healthy lactating women were treated orally with the anthelmintic praziquantel (Biltricide), and the resulting timedependent concentrations of the unchanged substance in plasma and milk were determined simultaneously. 5 of the women ("1st trial") received the single dose of 50 mg/kg; the other 5 women ("2nd trial") were treated three times at 4 hour intervals with 20 mg/kg. During the 1st trial a maximal plasma-concentration of 1.30 mg/l (arithmetic mean) was found. Subsequently the mean plasma-concentration decreased continuously and after 24 h it was only 0.4% of the maximum. During the 2nd trial the highest mean value (1.92 mg/l) was found 10 h after the first administration; after 32 h (24 h after the last administration) the mean value was 0.6% of the maximum mean value. The mean areas under the concentration/time-curves were 5.25 h. mg/l and 13.8 h . mg/l, respectively. The plasma half-life was estimated to be 3 hours. In both trials the concentration/time-curves of the milk corresponded qualitatively to those of the plasma. However, in each person and at each time, the concentration in the milk were essentially lower than those in the plasma. On the average, the plasma-concentrations were four times higher than the milk-concentrations. The mean values of the milk-concentrations increased and decreased correspondingly with those of the plasma-concentrations. At the end of the investigation (24 and 32 h, respectively, from the beginning) they were lower than the limit of determination (4 microgram/l). The mean excretion with the milk of the 10 women was 0.0008% of the given dose. From the comparative concentration/time-course, it could be demonstrated that the milk does not represent a deep department but readily equilibrates with the plasma. Equilibration obviously takes place by passive diffusion and not by active secretion.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 575330     DOI: 10.1007/BF03189426

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  4 in total

1.  A fluorometric method for the determination of praziquantel in blood-plasma and urine.

Authors:  J Pütter
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1979       Impact factor: 2.441

2.  Serum concentrations and renal excretion in humans after oral administration of praziquantel--results of three determination methods.

Authors:  K Patzschke; J Pütter; L A Wegner; F A Horster; H W Diekmann
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1979       Impact factor: 2.441

3.  Clinical pharmacology in normal volunteers of praziquantel, a new drug against schistosomes and cestodes. An example of a complex study covering both tolerance and pharmacokinetics.

Authors:  G Leopold; W Ungethüm; E Groll; H W Diekmann; H Nowak; D H Wegner
Journal:  Eur J Clin Pharmacol       Date:  1978-12-01       Impact factor: 2.953

4.  Quantitative determination of praziquantel in body fluids by gas liquid chromatography.

Authors:  H W Diekmann
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1979       Impact factor: 2.441

  4 in total
  6 in total

Review 1.  Clinical pharmacokinetics of anthelmintic drugs.

Authors:  G Edwards; A M Breckenridge
Journal:  Clin Pharmacokinet       Date:  1988-08       Impact factor: 6.447

2.  Survey of Obstetrician-Gynecologists in the United States About Taeniasis and Cysticercosis.

Authors:  Rebecca L Hall; Britta Anderson; Jay Schulkin; Paul T Cantey; Susan P Montgomery; Jeffrey L Jones
Journal:  Am J Trop Med Hyg       Date:  2016-11-14       Impact factor: 2.345

Review 3.  Drugs in human milk. Clinical pharmacokinetic considerations.

Authors:  H C Atkinson; E J Begg; B A Darlow
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

Review 4.  Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I).

Authors:  J B Besunder; M D Reed; J L Blumer
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

Review 5.  Systemic and Target-Site Pharmacokinetics of Antiparasitic Agents.

Authors:  Valentin Al Jalali; Markus Zeitlinger
Journal:  Clin Pharmacokinet       Date:  2020-07       Impact factor: 6.447

6.  Population Pharmacokinetics of Praziquantel in Pregnant and Lactating Filipino Women Infected with Schistosoma japonicum.

Authors:  Amaya L Bustinduy; Ruwanthi Kolamunnage-Dona; Mark H Mirochnick; Edmund V Capparelli; Veronica Tallo; Luz P Acosta; Remigio M Olveda; Jennifer F Friedman; William W Hope
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.